BioSolution Designs is the first multigenic gene and cell therapy engine creating a lean, capital efficient, and levered model to reduce risk in the notoriously risky biotechnology sector. BSD has architected a unique business model to advance several multigenic therapy enabling technologies and plans to spin out disease area focused therapeutic subsidiaries. Our internal IP holding structure enables BSD to spin out new therapeutic subsidiaries at low costs, all while generating tremendous shareholder ROI through long-term dividends.
| 9:00 AM PT | Presentation with Sam Glickstein |
| 9:20 - 10:00 AM PT | Q & A |
BioSolution Designs is a biotech invention studio and IP holding company creating the only multigenic DNA design and construction system for complex diseases. Through three distinct pillars, BSD will spin out new platforms, validate them through biotools sales to the research community, and create new IPO-ready therapeutic companies.